These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7521103)

  • 21. Peptidyl-prolyl cis-trans isomerases, cyclophilin, FK506-binding protein, and ninaA: four of a kind.
    Stamnes MA; Zuker CS
    Curr Opin Cell Biol; 1990 Dec; 2(6):1104-7. PubMed ID: 2099804
    [No Abstract]   [Full Text] [Related]  

  • 22. Purification and characterization of human T-cell cyclophilin expressed in Escherichia coli.
    Levy MA; Brandt M; Livi GP; Bergsma DJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):319-22. PubMed ID: 1990542
    [No Abstract]   [Full Text] [Related]  

  • 23. The mechanism of ciclosporin immunosuppression.
    Lorber MI
    Year Immunol; 1989; 4():253-63. PubMed ID: 2648704
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene expression of FK 506-binding protein.
    Kar S; Carr B
    Transplant Proc; 1991 Dec; 23(6):2880-2. PubMed ID: 1721303
    [No Abstract]   [Full Text] [Related]  

  • 25. Prolyl isomerases: role in protein folding.
    Schmid FX; Mayr LM; Mücke M; Schönbrunner ER
    Adv Protein Chem; 1993; 44():25-66. PubMed ID: 8317297
    [No Abstract]   [Full Text] [Related]  

  • 26. A new family of peptidyl-prolyl isomerases.
    Rudd KE; Sofia HJ; Koonin EV; Plunkett G; Lazar S; Rouviere PE
    Trends Biochem Sci; 1995 Jan; 20(1):12-4. PubMed ID: 7878731
    [No Abstract]   [Full Text] [Related]  

  • 27. Improved binding affinity for cyclophilin A by a cyclosporin derivative singly modified at its effector domain.
    Papageorgiou C; Florineth A; Mikol V
    J Med Chem; 1994 Oct; 37(22):3674-6. PubMed ID: 7966126
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporine and its analogue SDZ IMM 125 mediate very similar effects on T-cell activation--a comparative analysis in vitro.
    Baumann G; Andersen E; Quesniaux V; Eberle MK
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):43-8. PubMed ID: 1496687
    [No Abstract]   [Full Text] [Related]  

  • 29. Biology of cyclosporin A and FK506.
    Bierer BE
    Prog Clin Biol Res; 1994; 390():203-23. PubMed ID: 7536944
    [No Abstract]   [Full Text] [Related]  

  • 30. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
    Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
    Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclosporin G and metabolite binding to cyclophilin and a 50-kDa binding protein related to in vitro immunosuppression.
    Donnelly JG; Chen Y; Yatscoff RW; Copeland KR; Palaszynski EW; Soldin SJ
    Clin Chem; 1993 Jan; 39(1):122-5. PubMed ID: 8419033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin A.
    Ryffel B; Woerly G; Murray M; Eugster HP; Car B
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1074-83. PubMed ID: 8394698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine-cyclophilin interaction.
    Quesniaux VF; Schreier MH; Wenger RM; Hiestand PC; Van Regenmortel MH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):58-62. PubMed ID: 3284106
    [No Abstract]   [Full Text] [Related]  

  • 35. Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.
    Starzl TE; Abu-Elmagd K; Tzakis A; Fung JJ; Porter KA; Todo S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):914-9. PubMed ID: 1703351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of cyclosporine and metabolite binding to cyclophilin and a 50 kDa binding protein with in vitro immunosuppression: a preliminary report.
    Donnelly JG; Russell RL; Palaszynski EW; Copeland KR; Yatscoff RW; Chan MM; Soldin SJ
    Clin Biochem; 1991 Feb; 24(1):71-4. PubMed ID: 2060135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The characterisation of peptidyl prolyl cis-trans isomerase (PPI) activity associated with the endoplasmic reticulum.
    Bose S; Freedman RB
    Biochem Soc Trans; 1992 Aug; 20(3):256S. PubMed ID: 1426548
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular mechanisms of immunosuppressive agents.
    Borel JF; Baumann G
    Bull Mem Acad R Med Belg; 1994; 149(1-2):97-101; discussion 101-3. PubMed ID: 7531051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural studies of complexed FK-506 binding protein.
    Clardy J
    Ann N Y Acad Sci; 1993 Jun; 685():37-45. PubMed ID: 7689808
    [No Abstract]   [Full Text] [Related]  

  • 40. Study of the immunosuppressive properties of cyclosporine analogues.
    Reem GH; el Rouby S; Shi Y
    Ann N Y Acad Sci; 1993 Jun; 685():336-8. PubMed ID: 8363236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.